Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world

Saved in:
Bibliographic Details
Main Author: Maria José Sá
Format: Article
Language:English
Published: Thieme Revinter Publicações 2012-10-01
Series:Arquivos de Neuro-Psiquiatria
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012001000001&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!